|
Report No. : |
319798 |
|
Report Date : |
06.05.2015 |
IDENTIFICATION DETAILS
|
Name : |
BRUKER BIOSPIN AG |
|
|
|
|
Registered Office : |
Industriestrasse 26 8117 Fällanden/ZH |
|
|
|
|
Country : |
Switzerland |
|
|
|
|
Financials (as on) : |
31.12.2014 |
|
|
|
|
Date of Incorporation : |
24.06.1965 |
|
|
|
|
Legal Form : |
Company limited by shares |
|
|
|
|
Line of Business : |
Subject is engaged in the production and sale of scientific devices as well as the planning and construction of research plants and institutes, in particular in the sector of the magnetic resonance. |
|
|
|
|
No. of Employee : |
500 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2014
|
Country Name |
Previous Rating (30.09.2014) |
Current Rating (31.12.2014) |
|
Switzerland |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
SWITZERLAND ECONOMIC OVERVIEW
Switzerland is a peaceful, prosperous, and modern market economy with low unemployment, a highly skilled labor force, and a per capita GDP among the highest in the world. Switzerland's economy benefits from a highly developed service sector, led by financial services, and a manufacturing industry that specializes in high-technology, knowledge-based production. Its economic and political stability, transparent legal system, exceptional infrastructure, efficient capital markets, and low corporate tax rates also make Switzerland one of the world's most competitive economies. The Swiss have brought their economic practices largely into conformity with the EU's to enhance their international competitiveness, but some trade protectionism remains, particularly for its small agricultural sector. The fate of the Swiss economy is tightly linked to that of its neighbors in the euro zone, which purchases half of all Swiss exports. The global financial crisis of 2008 and resulting economic downturn in 2009 stalled export demand and put Switzerland in a recession. The Swiss National Bank (SNB) during this period effectively implemented a zero-interest rate policy to boost the economy as well as prevent appreciation of the franc, and Switzerland's economy began to recover in 2010. The sovereign debt crises currently unfolding in neighboring euro-zone countries pose a significant risk to Switzerland's financial stability and are driving up demand for the Swiss franc by investors seeking a safe-haven currency. The independent SNB has upheld its zero-interest rate policy and conducted major market interventions to prevent further appreciation of the Swiss franc, but parliamentarians have urged it to do more to weaken the currency. The franc's strength has made Swiss exports less competitive and weakened the country's growth outlook; GDP growth fell below 2% per year during 2011-13. Switzerland has also responded to increasing pressure from individual neighboring countries, the EU, the US, and international institutions to reform its banking secrecy laws. Consequently, the government agreed to conform to OECD regulations on administrative assistance in tax matters, including tax evasion. The government has renegotiated its double taxation agreements with numerous countries, including the US, to incorporate the OECD standard, and is considering the possibility of imposing taxes on bank deposits held by foreigners. These steps hurt Switzerland's long history of bank secrecy.
|
Source
: CIA |
BRUKER BIOSPIN AG
Operating
address:
Industriestrasse
26
8117 Fällanden/ZH
Switzerland/CH
Telephone: 044
8259111
Fax: 044
8259696
Web
site: http://www.bruker.com
E-mail: Info.bbio.ch@bruker.com
WIN
Worldbox No.: CH0000444189
VAT-No.: CHE101138357
UID-No.: CHE101138357
Established: 1965
Line
of Business: Measurement and
control technology, Medical technology
Industry
Division: Manufacturing
Industry-code (NACE): 2651 Manufacture of instruments and appliances
for measuring, testing and navigation
2660 Manufacture of irradiation,
electromedical and electrotherapeutic equipment
Import/Export: Import, Export
Quality
certification: ISO 9001:2008
Banks: CS Credit Suisse
Coverage: Company
Figures: estimated
Financial
year: 2015
Employees: 500
Sales: CHF 260,000,000.--
The company is engaged in the production and
sale of scientific devices as well as the planning and construction of research
plants and institutes, in particular in the sector of the magnetic resonance.
Real
Estate: The company owns buildings.
Company
No: 020.3.924.534-8
UID-No.: CHE101138357
Legal
form: Company limited by
shares
Registration: 24.06.1965
Legal
status: active
Responsible
Register: Handelsregister des Kantons
Zürich
History: Date of Statutes:
10.04.1981
Date of
Statutes: 26.11.2013
Date of
Statutes: 13.02.2008
Date of
Statutes: 20.12.2007
Date of
Statutes: 26.09.2001
Date of
Statutes: 16.06.1998
Date of
Statutes: 21.03.1997
Entry Deleted Name
05.10.2001 Bruker
BioSpin AG
26.06.1998 Spectrospin AG
26.06.1998 05.10.2001 Bruker AG
Entry Deleted Legal domicile
active Fällanden,
Switzerland
Entry Deleted Address
active Industriestrasse
26, 8117 Fällanden, Switzerland/CH
Entry Deleted Capital
active Share
Capital CHF 5,000,000, paidup CHF 5,000,000
Entry Deleted Capital Structure
05.10.2001 50,000
Registered shares of CHF 100.--
Title Name
President Thomas
Bachmann
Citizen:
Buchholterberg, Switzerland
Residential
address: Zollikon, Switzerland
joint
signature of two
Registered
since: 07.01.2014
Director Dr. Werner
E. Maas
Citizen:
Netherlands
Residential
address: Merrimac /MA, United States of America
joint
signature of two
Registered
since: 08.07.2008
Title Name
Director Dr. René
Jeker
Citizen:
Büsserach, Switzerland
Residential
address: Hombrechtikon, Switzerland
joint
signature of two
Registered
since: 01.10.1997
Director Dr. Rainer
Kümmerle
Citizen:
Germany
Residential
address: 8620 Wetzikon /ZH, Switzerland
joint
signature of two
Registered
since: 17.05.2010
Director Stephan
Westermann
Citizen:
Germany
Residential
address: Bergneustadt , Germany
joint
signature of two
Registered
since: 23.09.2013
Vice-Director Dr. Daniel Eckert
Citizen:
Basel, Switzerland
Residential
address: 8184 Bachenbülach/ZH, Switzerland
joint
signature of two
Registered
since: 17.05.2010
Vice-Director Volker Ilg
Citizen:
Germany
Residential
address: Zollikon, Switzerland
joint
signature of two
Registered
since: 23.09.2013
Vice-Director Pietro Lendi
Citizen:
Uznach, Switzerland
Residential
address: 8730 Uznach/SG, Switzerland
joint
signature of two
Registered
since: 17.05.2010
Vice-Director Remo Lüchinger
Citizen:
Oberriet SG, Switzerland
Residential
address: Zürich, Switzerland
joint
signature of two
Registered
since: 17.05.2010
Member
with signing authority Peter Kistler
Citizen:
Reichenburg, Switzerland
Residential
address: Rapperswil-Jona, Switzerland
joint
signature of two
Registered
since: 07.05.2014
Member
with signing authority Dr. Kurt
Schenker
Citizen:
Däniken, Switzerland
Residential
address: Maur, Switzerland
joint
signature of two
Registered
since: 07.05.2014
Member
with signing authority Dr. Peter
Scherer
Citizen:
Killwangen, Switzerland
Residential
address: Dübendorf, Switzerland
joint
signature of two
Registered
since: 07.05.2014
Member
with signing authority Urs Widmer
Citizen:
Lindau, Switzerland
Residential
address: Neftenbach, Switzerland
joint
signature of two
Registered
since: 07.05.2014
Title Name
Auditor Ernst
& Young AG
Residential
address: Zürich, Switzerland
Id:
CHE-491.907.686
Registered
since: 17.11.2000
Name: Bruker Corporation
City/Country: Billerica/Massachusetts, United
States of America/US
Consolidation: consolidated
Industry: Trade/Industry
Fiscal year end: 31.12.2014 31.12.2013 31.12.2012 31.12.2011 31.12.2010
Number of months: 12 12 12 12 12
Currency: th.
USD th. USD th. USD th. USD th.
USD
Statement norm: US-GAAP US-GAAP US-GAAP
Intangible fixed
assets 211,600.0 233,000.0 232,900.0 236,600.0 234,400.0
Other tangible
fixed assets 249,900.0 299,500.0 283,600.0
Tangible fixed
assets 249,900.0 299,500.0 283,600.0 249,000.0 233,700.0
Financial fixed
assets 0.0 0.0
other fixed assets 37,000.0 23,900.0 30,200.0 30,800.0 30,600.0
Fixed assets 498,500.0 556,400.0 546,700.0 516,400.0 498,700.0
Stocks 477,400.0 589,800.0 611,500.0 576,200.0 511,000.0
Trade accounts
receivable 293,200.0 307,600.0 289,300.0
Liquid assets 319,500.0 438,700.0 310,600.0 246,000.0 230,400.0
Securities 178,000.0
other trade
accounts 98,200.0 95,800.0 98,300.0
Other current
assets 595,700.0 534,500.0 408,900.0
Current assets 1,366,300.0 1,431,900.0 1,309,700.0 1,194,100.0 1,051,100.0
Total assets 1,864,800.0 1,988,300.0 1,856,400.0 1,710,500.0 1,549,800.0
Capital 82,800.0 64,600.0 49,800.0
Other shareholders
funds 683,100.0 781,500.0 656,800.0
Total shareholders equity 765,900.0 846,100.0 706,600.0 621,500.0 524,700.0
Minority interests 5,800.0 4,100.0 3,100.0 3,400.0 2,700.0
long term debt
(financial debts) 354,200.0 388,000.0 370,800.0 215,300.0 81,700.0
Provisions 39,200.0 39,400.0
Other non current
liabilities 156,200.0 101,500.0 94,100.0 75,300.0 69,800.0
Non current liabilities 510,400.0 489,500.0 464,900.0 329,800.0 190,900.0
short term debt
(financial debts) 800.0 700.0 1,300.0
Trade accounts
payable 76,000.0 74,800.0 69,600.0
Accruals 199,600.0 192,800.0
other accounts
payable 505,900.0 373,500.0 418,100.0
other current
liabilities 505,900.0 573,100.0 610,900.0
Current liabilities 582,700.0 648,600.0 681,800.0 755,800.0 831,500.0
Shareh. equity, min. int. & liabilities 1,864,800.0 1,988,300.0 1,856,400.0 1,710,500.0 1,549,800.0
Net sales 1,803,700.0 1,830,700.0 1,766,500.0 1,651,700.0 1,304,900.0
Other operating
revenue 5,200.0 8,700.0 24,900.0
Operating revenue 1,808,900.0 1,839,400.0 1,791,400.0
Cost of goods sold 1,045,600.0 1,034,200.0 962,000.0
Gross profit 763,300.0 805,200.0 829,400.0
Other operating
expenses 657,900.0 657,000.0 673,400.0
Operating result 105,400.0 148,200.0 156,000.0 156,200.0 156,300.0
Interest revenues 1,000.0 900.0
other financial
revenues 900.0 2,500.0
Financial income 1,900.0 3,400.0
Interest expenses 4,100.0 13,400.0 14,300.0
other financial
expenses 12,100.0 6,800.0
Financial expenses 4,100.0 25,500.0 21,100.0
Financial result -4,100.0 -23,600.0 -17,700.0
Result before extraordinary items 101,300.0 124,600.0 138,300.0
Extraordinary
Result 0.0 0.0
Result before taxes 101,300.0 124,600.0 138,300.0
Taxes 41,700.0 42,800.0 60,100.0
Result before
minority interests 59,600.0 81,800.0 78,200.0
minority interests 2,900.0 1,700.0 700.0
Result for the financial year 56,700.0 80,100.0 77,500.0 92,300.0 95,400.0
Depreciation 61,300.0 59,100.0
Cash flow 143,100.0 137,300.0
Cash flow from
operating activities 145,000.0 133,100.0
Investments in
tangible fixed assets 50,300.0 72,800.0
Cash flow from
investing activities -60,000.0 -93,200.0
Cash flow from
financing activities 26,500.0 34,400.0
Others 16,600.0 -9,700.0
Change in
liquidity 128,100.0 64,600.0
Liquidity at
beginning of the year 310,600.0 246,000.0
Liquidity at end
of the year 438,700.0 310,600.0
Material costs 1,034,200.0 962,000.0
Research and
Development 174,200.0 190,500.0 195,300.0
Added value 105,400.0 199,300.0 211,700.0
Working Capital 694,600.0 822,600.0 831,200.0
Sales per Employee 300.6 295.3 276.0
Gross cost land
and buildings 336,600.0 305,700.0
Gross cost other
tangible fixed assets 362,600.0 337,300.0
Gross cost total 699,200.0 643,000.0
Full time units at
year end 6,000 6,200 6,400
No.
of Owner/-s: 1
Owner: The company is foreign owned.
Class: 100%
Type: indirect, Group-Level
1
Name: Bruker Corporation
City/Country: Billerica/Massachusetts, United
States of America/US
Interest: 100,00% voting right,
100,00% capital interest
Class: 100%
Type: direct
Name: Bruker Invest AG
City/Country: Fällanden/ZH, Switzerland/CH
Interest: 100,00% voting right,
100,00% capital interest
Name: Bruker BioSpin
International AG
City/Country: Fällanden/ZH, Switzerland/CH
Name: Bruker Pty Ltd
City/Country: Alexandria/New South Wales,
Australia/AU
It is believed that the company has no
investments.
Balance sheet publication:
The subject company does not publish balance
sheet or turnover figures.
Control date Year No. Amount CHF Status
04.04.2014 2014 0 Legal
actions
31.12.2013 2013 0 Legal
actions
31.12.2012 2012 0 Legal
actions
31.12.2011 2011 0 Legal
actions
31.12.2010 2010 0 Legal
actions
31.12.2009 2009 0 Legal
actions
31.12.2008 2008 0 Legal
actions
31.12.2007 2007 0 Legal actions
31.12.2006 2006 0 Legal
actions
31.12.2005 2005 0 Legal
actions
31.12.2004 2004 0 Legal
actions
Official bankruptcy reports:
No bankruptcy publications available on the subject.
An updated legal action check is only available against proof of interest. e.g. a copy of an enquiry letter, and order or invoice relating to the subject company.
Debt Collection Case:
SEP 2013: CHF 4'042.00.
Financial Statements: The company does not disclose any financial statements. Third parties are not permitted any insight into the financial affairs. It is therefore difficult to make a proper assessment of the actual situation.
Financial Situation: The financial situation is considered to be good.
Payment experiences: Financial obligations are paid very punctually.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.63.52 |
|
|
1 |
Rs.95.96 |
|
Euro |
1 |
Rs.70.54 |
INFORMATION DETAILS
|
Analysis Done by
: |
SUB |
|
|
|
|
Report Prepared
by : |
ANK |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment record
(10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.